Results 121 to 130 of about 16,033 (175)

Omicron respiratory threat in renal transplant recipients. [PDF]

Caspian J Intern Med
Akbari R, Abolghasemi S, Shafiekhani M, Asgharpour M, Zare Z, Nikoupour H, Roozbeh J, Mahmoudi Chalmiani E, Oliaie F, Baziboroun M, Nezami S.   +10 more
europepmc   +1 more source

Intrathecal Chemotherapy Through Ommaya Reservoir in Leptomeningeal Metastasis From Cervical Cancer: A Rare Case Report and Literature Review. [PDF]

J Obstet Gynaecol Res
Ahn C, Seo H, Jo D, Han B, Choi E, Kim S, Chung SW, Kang OJ.   +7 more
europepmc   +1 more source

Risk factors for irinotecan-induced hepatotoxicity: a retrospective cohort study. [PDF]

Front Oncol
Alherz FA, Alnakhli AM, Alqarni AM, Alshammari AF, Ruwayi AM, Alyamani RM, Al-Salloum H, Al-Yamani MJ, Shuweihdi F.   +8 more
europepmc   +1 more source

Graft rejection across solid organ transplants: mechanisms, monitoring, and immunosuppressive therapeutics. [PDF]

Front Surg
Danso EA, Oduoye MO, Enuh WC, Wamiq U, Shuja H, Sawaira F, Fatima H, Tameez-Ud-Din S.   +7 more
europepmc   +1 more source

Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss. [PDF]

Cancers (Basel)
Gaumond SI, Shrestha S, Kamholtz I, Beraja GE, Jimenez JJ.   +4 more
europepmc   +1 more source

From in silico prediction to experimental validation: Identification of drugs and novel synergistic combinations that inhibit growth of inflammatory breast cancer cells. [PDF]

PLoS One
Salim EA, Ji X, Tarpley M, Dixon MS, Zheng W, Scott JE, Williams KP.   +6 more
europepmc   +1 more source

Screening of purine nucleoside analogues against intracellular Toxoplasma gondii

Elati HAA, Van Calenbergh S, Sheiner L, de Koning HP.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Antimetabolites

Current Opinion in Oncology, 1992
Research efforts over the past year further elucidate the determinants of sensitivity and mechanisms of resistance to the antimetabolites fluorouracil, methotrexate, and cytarabine. Progress has been made in clarifying the complex regulation of target enzyme expression for these antimetabolites.
A P, Chen, J L, Grem
openaire   +4 more sources

Platinum-Nucleos(t)Ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and Perspectives

Pharmaceutics, 2023
Nucleoside analogues (NAs) are a family of compounds which include a variety of purine and pyrimidine derivatives, widely used as anticancer and antiviral agents.
Federica De Castro, Michele Benedetti, Francesco Paolo Fanizzi   +2 more
exaly   +3 more sources

Antimetabolite Radiosensitizers

Journal of Clinical Oncology, 2007
Radiosensitization with antimetabolites has improved clinical outcome for patients with solid malignancies, especially cancers of the GI tract, cervix, and head and neck. Fluorouracil (FU) and hydroxyurea have been widely used clinically during the last four decades, and promising results have been observed more recently with gemcitabine. Although the
Donna S, Shewach, Theodore S, Lawrence
openaire   +2 more sources